Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyME
2024-520166-63-00Phase 4Authorised
- Sponsor
- UZ Brussel
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mifepristone and misoprostol in Early pregnancy failure (EPF) (2 arms), sponsored by UZ Brussel. Primary endpoint: Complete trophoblastic tissue expulsion. Planned start Nov 2025; status: authorised.
02
Drugs
mifepristonemisoprostol
03
Conditions
Early pregnancy failure (EPF)
Beyond the preview
Go deeper on 2024-520166-63-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520166-63-00.